We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker; Dr. Diana Rafael, main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) VHIR
Abstract: The constant development of new synthetic drug delivery systems in the last years have been highly contributing to the advancement of new treatments for a wide-range of challenging diseases, for which the conventional treatments are not efficient. The use of nanoparticles and hydrogels have been a breakthrough in clinical application, with hundreds of new products enrolling clinical trials and being approved in the clinical practice. In the CB-DDT group we are experts in the development of new therapeutic strategies based on nanoparticles and hydrogels for several different clinical applications. This presentation will be divided in two parts: The first one dedicated to the most promising works regarding the development of nanoparticles encapsulating different drugs and biomolecules for the systemic treatment of different pathological conditions, and the second one dedicated to the most promising results regarding the use of biodegradable, smart hydrogels for cancer local treatment.
Bio Sketch: Diana Rafael, is a Principal Investigator at VHIR. She has a PhD in Pharmaceutical Technology (2017), and since 2013 she has been associated with the Clinical Biochemistry: Drug Delivery and Therapy Group from VHIR, where she initiated a research line dedicated to the production and characterization of Delivery Systems. Diana participated in more than 12 highly competitive national and international research projects and her research work originated 2 patents and more than 40 peer-reviewed publications. This year, Diana was granted with a Global Marie Sk³odowska-Curie Postdoctoral Fellowship and a Grant from the Spanish Association against the Pancreatic Cancer. Moreover, since January Diana has been implementing a new section within the FVPR/U20 platform of the Nanbiosis, certified by ISO9001:2015, dedicated to the synthesis and characterization of Nanosystems.
Host: Dr. Ibane Abasolo, head of group Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) VHIR
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.